Biomarker-driven phase 2 study of MK-2206 and selumetinib...

Investigational New Drugs 2015 / 6 Vol. 33; Iss. 3

Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer

Do, Khanh, Speranza, Giovanna, Bishop, Rachel, Khin, Sonny, Rubinstein, Larry, Kinders, Robert J., Datiles, Manuel, Eugeni, Michelle, Lam, Michael H., Doyle, L. Austin, Doroshow, James H., Kummar, Shi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-015-0212-z
Date:
June, 2015
File:
PDF, 1.40 MB
english, 2015
Conversion to is in progress
Conversion to is failed